Market veteran Ambareesh Baliga suggests pharmaceutical stocks offer a safe haven amidst currency volatility and cautious foreign investor sentiment. He advises focusing on top-tier pharma companies. Baliga also expresses caution on jewellery stocks due to increased gold import duties and anticipates margin pressures, while maintaining a positive outlook on Tata Motors and a bullish long-term view on Solar Industries India.
